|
Market Closed -
Nasdaq
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 150.42 USD | -2.02% |
|
-2.51% | +43.71% |
| 08-04 | Palvella Therapeutics, Inc., Q2 2026 Earnings Call, Aug 04, 2026 | |
| 08-04 | Palvella Therapeutics Q2 Net Loss Widens | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.02% | -2.51% | -4.34% | +43.19% | +43.71% | +203.57% | - | - | - | 2.21B | |
| +0.17% | +3.62% | +41.81% | +62.11% | +84.44% | +70.94% | +109.68% | +28.65% | - | 73.25B | |
| +1.73% | +16.15% | +15.69% | +28.77% | +21.37% | +51.73% | +93.89% | +224.14% | +6,297.06% | 61.95B | |
| +0.11% | -3.10% | +18.59% | +19.89% | -26.19% | +0.94% | +491.16% | +463.17% | +931.81% | 28.02B | |
| +5.24% | +5.65% | +31.37% | +47.48% | +54.52% | +56.71% | +21.30% | -56.86% | - | 24.15B | |
| +1.26% | -0.05% | +1.39% | +4.39% | -2.57% | -17.59% | -15.96% | -74.52% | - | 23.01B | |
| -0.71% | -4.11% | +17.15% | +92.68% | +230.42% | +243.99% | +423.83% | +1,733.40% | +857.44% | 18.35B | |
| 0.00% | +5.57% | +12.57% | +24.46% | +3.80% | +39.57% | -14.30% | -29.40% | +92.67% | 19.46B | |
| +3.83% | +2.65% | +11.53% | +27.89% | +38.32% | +21.42% | +557.58% | - | - | 15.92B | |
| +1.53% | +3.49% | -5.01% | +6.58% | +21.20% | +40.68% | +151.75% | +190.91% | +384.23% | 12.96B | |
| -0.90% | -1.50% | +18.30% | +18.86% | +32.40% | +341.49% | +211.04% | +47.06% | +1,145.04% | 12.53B | |
| -0.10% | -2.04% | -5.26% | +0.41% | -9.95% | +33.96% | +191.74% | +549.05% | +5,624.56% | 12.13B | |
| +0.55% | -10.70% | +3.00% | -20.04% | -19.47% | -47.00% | +180.00% | +121.14% | - | 10.63B | |
| +0.31% | -15.18% | -7.17% | -19.98% | -26.70% | -51.24% | +628.41% | +79.55% | +83.85% | 10.2B | |
| +0.30% | -0.46% | -5.09% | +1.22% | +19.77% | +95.38% | +134.59% | +151.57% | +539.50% | 10.55B | |
| +3.08% | +4.94% | +7.57% | +53.85% | +229.12% | +536.48% | +780.16% | -37.04% | -26.65% | 9.22B | |
| -2.16% | -5.44% | +3.80% | -7.75% | +9.93% | -1.55% | +122.02% | -24.98% | - | 9.18B | |
| -0.04% | +0.43% | +1.03% | +144.15% | +82.00% | +184.87% | +424.91% | +292.77% | - | 8.99B | |
| -0.71% | +0.96% | +6.39% | +23.43% | +29.58% | +86.32% | +20.01% | +160.07% | - | 8.96B | |
| -1.00% | +2.29% | +3.61% | +28.74% | +14.10% | +29.92% | +412.24% | +329.03% | - | 8.01B | |
| Average | +0.52% | +0.06% | +8.35% | +29.02% | +41.49% | +96.03% | +259.16% | +230.43% | +1,592.95% | 18.98B | |
| Weighted average by Cap. | +0.88% | +2.98% | +16.55% | +34.08% | +43.85% | +74.38% | +202.48% | +212.04% | +2,700.43% |
- Stock Market
- Stocks
- PVLA Stock
- Sector Palvella Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
